Home Alzheimer’s Disease Study Identifies Acquired Resistance After Treatment for Patients with NSCLC

Study Identifies Acquired Resistance After Treatment for Patients with NSCLC

Acquired resistance after treatment for non-small cell lung cancer (NSCLC) with third- generation EGFR tyrosine kinase inhibitors (TKI) was associated with diverse pathways, according to a recent study published in Cancer.

Moreover, the treatment with osimertinib was associated with loss of EGFR T790M and emergence of EGFR-independent resistance mechanisms.

“Our data reveal the unique characteristic of resistance mechanisms acquired after treatment with third-generation EGFR TKIs in patients who have advanced NSCLC harboring the EGFR T790M mutation,” wrote the researchers.

In the population, there were 36 patients with posttreatment biopsies, of which EGFR-dependent mechanisms were observed in 10 patients (5 in the osimertinib group and 5 in the olmutinib group). EGFR-independent mechanisms were found in 21 patients (11 in the osimertinib group and 10 in the olmutinib…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments